Latest Commercialisation News

Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore marketing and distribution of its high-reactivity metakaolin product, AusPozz™, across Australia and key international markets.

Harvest Technology Group has forged a pivotal exclusive reseller agreement with Pyxis Controls to expand its Nodestream™ technology across the MENATISA region, targeting critical sectors like national security and energy.

Critical Resources Limited has secured a 12-month exclusive option to evaluate advanced solid-state lithium-ion battery technology from the South Dakota School of Mines & Technology, aiming to enhance battery safety, performance, and commercial potential.

Metallium Ltd has secured exclusive rights to apply its breakthrough Flash Joule Heating technology to the heavy rare earth-rich Harts Range Project, achieving an unprecedented 20-fold upgrade in rare earth concentration. This deal positions Metallium as a key player in Western critical minerals supply amid global geopolitical tensions.

New Frontier Minerals has locked in a decade-long exclusive agreement with Metallium to apply cutting-edge Flash Joule Heating technology to its Harts Range ore, achieving unprecedented rare earth enrichment. This partnership targets strategic US defense and magnet markets, marking a pivotal step for the project’s commercial future.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Cobre Limited has landed a $4 million strategic investment from Tribeca Investment Partners to accelerate development of its Ngami In-Situ Copper Recovery project in Botswana, marking a key step toward commercialising this promising copper resource.

Livium Ltd has locked in exclusive worldwide rights to a cutting-edge microwave technology from the University of Melbourne, promising high recovery rates and energy savings in rare earth and platinum group metals extraction.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Calix Limited has secured a pivotal $35 million joint development agreement with Rio Tinto to advance its Zesty Green Iron Demonstration Plant in Western Australia, backed by a substantial ARENA grant. This collaboration aims to pioneer low-emission steel production using innovative hydrogen and electric heating technology.

Radiopharm Theranostics has reached the halfway mark in enrolling patients for its Phase 2b trial of RAD101, a novel imaging agent targeting brain metastases. Early data suggest RAD101 may outperform MRI in distinguishing tumor recurrence from radiation damage.